
miR-222 confers the resistance of breast cancer cells to Adriamycin through suppression of p27kip1 expression
Keywords: Adr, Adriamycin; microRNA, miRNA; Bak1, Bcl-2 Antagonist Killer 1; 3ʹUTR, 3′-untranslation region; SOCS1, suppressor of cytokine signaling 1; CDKN1B, cyclin-dependent kinase inhibit 1BmiR-222; Adriamycin; Drug resistance; p27kip1; Breast cancer